Glaxosmithkline Pharmaceuticals informs about annual report

19 Jun 2019 Evaluate

Pursuant to clause 34 of the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that it has submitted the soft copy of AGM Notice & Annual Report for year ended 31st March, 2019 of the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2364.95 1.35 (0.06%)
30-Jan-2026 10:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1591.65
Dr. Reddys Lab 1220.10
Cipla 1321.75
Zydus Lifesciences 886.60
Lupin 2147.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×